Search
for
Sort by
Research 181–210 of 677
- A review of the treatment of male pattern hair loss
- Microneedle-Based Approaches for Skin Disease Treatment
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat
- Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride
- Inhibition of Hair Growth by Testosterone in the Presence of Dermal Papilla Cells from the Frontal Bald Scalp of the Postpubertal Stumptailed Macaque<sup>1</sup>
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- The Potential Role of Minoxidil in the Hair Transplantation Setting
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Microneedles mediated bioinspired lipid nanocarriers for targeted treatment of alopecia
- Post-finasteride syndrome: An emerging clinical problem
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Androgenetic alopecia; drug safety and therapeutic strategies
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- The beneficial effects of Pumpkin (<i>Cucurbita pepo</i>L.) seed oil for health condition of men
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness?
- Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens
- New lifestyle drugs and somatoform disorders in dermatology
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Co-loading of finasteride and baicalin in phospholipid vesicles tailored for the treatment of hair disorders
- Finasteride and androgenic alopecia; from therapeutic options to medical implications
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency